Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC

INTRODUCTION: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the survival of colorectal cancer (CRC) patients with peritoneal metastases. Patient selection is key since this treatment is associated with high morbidity. Patients with peritoneal recurrence within 1 year af...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: Sluiter, Nina R., Rovers, Koen P., Salhi, Youssra, Vlek, Stijn L., Coupé, Veerle M. H., Verheul, Henk M. W., Kazemier, Geert, de Hingh, Ignace H. J. T., Tuynman, Jurriaan B.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2018
Témata:
Colorectal Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028868/
https://ncbi.nlm.nih.gov/pubmed/29855834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6539-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky